• Modern guidelines improve late relapse rates, outcomes in testicular cancer

    11 days ago - By Healio

    CHICAGO - Centralized treatment and adherence to modern guidelines may account for “relatively low” rates of late relapse and improved long-term outcomes after treatment for testicular cancer, according to a speaker at ASCO.
    “Late relapses as a unique entity with a worse prognosis compared earlier relapses have been described for decades. However, published data reports a wide range, both in the prevalence and for prognosis,” Torgrim Tandstad, MD, PhD, from St. Olav's University Hospital, Trondheim, Norway, said in a presentation.
    Many of the
    Read more ...